Acorda Therapeutics Company
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.
Investors
Technology:
Immunotherapy
Industry:
Loss of Proteostasis
Headquarters:
United States
Founded Date:
1995
Employees Number:
251-500
Funding Status:
IPO
Estimated Revenue:
$50M to $100M
Register and Claim Ownership